Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.85559 | 36 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.80002 | 35 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.80387 | 35 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.73526 | 35 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.72625 | 34 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.01666 | 40 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.82451 | 34 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.77308 | 35 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.74832 | 34 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.77376 | 35 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.80755 | 36 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.76039 | 35 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.79592 | 35 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.79065 | 35 |